XML 22 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Note 8 - Investments in Marketable Securities
9 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note 8 - Investments in Marketable Securities

 

All investments are classified as “Current assets” because they are available for sale at any time. These “available-for-sale” marketable securities are stated at fair value. The Company uses quoted prices in active markets for identical assets (consistent with the Level 1 definition in the fair value hierarchy) to measure the fair value of its investments on a recurring basis pursuant to ASC 820, Fair Value Measurement. As of June 30, 2022 and September 30, 2021, there were net accumulated pretax unrealized gains of $187,018,000 and $244,093,000, respectively, recorded in the accompanying Consolidated Balance Sheets. Most of the accumulated pretax unrealized gains were in the common stocks of three U.S. financial institutions and one foreign manufacturer.

 

For the nine months ended June 30, 2022, the Company recorded and included in its net income the net unrealized losses on marketable securities of $57,075,000, as compared with the net unrealized gains on marketable securities of $131,754,000, in the prior year period.

 

In December 2021 and March 2022, the Company sold part of its marketable securities for approximately $80,570,000, realizing net gains of $14,249,000, and borrowed an additional net $43,000,000 from the margin loan account to primarily purchase additional marketable securities with a total cost of approximately $117,678,000.

 

Investments in marketable securities as of June 30, 2022 and September 30, 2021 are summarized below.

 

Investment in Marketable Securities

 

  

June 30, 2022

  

September 30, 2021

 
  

Aggregate

fair value

  

Adjusted

cost basis

  

Pretax

unrealized

gains

  

Aggregate

fair value

  

Adjusted

cost basis

  

Pretax

unrealized

gains

 

Marketable securities

                        

Common stocks

 $341,855,000  $154,837,000  $187,018,000  $347,573,000  $103,480,000  $244,093,000